428
M. Weymann – H. Kunz · Stereoselective Synthesis of Quinolizidine Alkaloids: (–)-Lasubin II
purification was not necessary. Characterization of the com- 5 mmol) was added. After 3 h, the magnesium has been dis-
pound was carried out via its subsequent products.
solved, and the Grignard solution was given via a steel sy-
ringe to a cooled (−78 ◦C) suspension of CuI (0.9 g, 5 mmol)
in tetrahydrofuran (15 mL). The clear brown solution was
warmed up to −50 ◦C within 2 h and was cooled again
N-(2,3,4,6-Tetra-O-pivaloyl-β-D-galactopyranosyl)-
2-(3,4-dimethoxyphenyl)-5,6-dehydropiperidin-4-one (5)
◦
to −78 C. BF3· Et2O (0.6 mL, 5 mmol) was added. Af-
In analogy to a reported procedure [8], imine 3 (7.3 g,
10 mmol) was dissolved in dry tetrahydrofuran (50 mL) and
cooled to −78 ◦C. A 1 M solution (11 mL) of ZnCl2 in
THF/CH2Cl2 (1 : 1, v/v) was added. After 10 min Danishefky
diene 4 [9] (2.5 mL, 12.5 mmol) was added. After stirring for
30 min at −78 ◦C, the solution was stirred at −20 ◦C for 36 h
(monitoring by TLC). Aqueous 1 N HCl (10 mL) was added,
and the solvent evaporated in vacuo. Diethyl ether (200 mL)
was added, the acidic aqueous solution separated, and the or-
ganic solution extracted three times with aq. NaHCO3 solu-
tion. Remaining zinc salts were removed by extraction with
◦
ter 15 min (temperature < −55 C) a solution of dehydro-
piperidinone 5 (0.73 g, 1 mmol) in tetrahydrofuran (10 mL)
was added and the mixture stirred for 18 h. The mixture was
diluted with diethyl ether (50 mL) and treated with conc.
aq. NH4OH/NH4Cl 1 : 1 (v/v). The aqueous layers were ex-
tracted twice with diethyl ether, the combined ether solutions
were washed with brine and dried with MgSO4. After evap-
oration of the solvent the remainder was purified by chro-
matography on silica (15 × 3 cm) in light petroleum/ethyl
acetate (4 : 1). Yield: 0.46 g (56 %) of a mixture of 6 and 7.
The composition was determined by 1H NMR spectroscopy,
ratio of 6/7 4 : 1. Diastereomeric ratio for 6: > 10 : 1. – NMR
data for 6: 1H NMR (400 MHz, CDCl3): δ = 1.06, 1.15, 1.20
and 1.23 (4s, each 9H, piv-CH3), 1.48 (m, 2-3H, CH2), 1.74
(m, 2H, CH2), 2.08 (m, 1H, CH2), 2.44 (m, 3H, CH2C=O,
CH2C=Oꢀ), 2.57 (dd, 1H, Jvic = 11.0 Hz, Jgem = 14.6 Hz,
CH2C=O), 3.29 (dd, 1H, J1 = 7.0 Hz, J2 = 7.5 Hz, alkyl-
CHN), 3.50 (m, 2H, CH2Cl), 3.77 – 3.94 (m, 8H, H-5ꢀ, H-6aꢀ,
R
10 % TitriplexꢀIII solution (2×50 mL). After washing with
brine and drying with MgSO4, the solvent was evaporated in
vacuo, and the product was purified by chromatography on
silica (20×5 cm) in light petroleum/ethyl acetate 2 : 1.
Yield: 5.26 g (72 %, based on glycosylamine 1); pale
yellow crystalline solid; m. p. 148 ◦C; [α]D22 = 33.7 (c =
1.0, CHCl3); Rf = 0.08 (light petroleum/ethyl acetate 3 : 1).
Diastereomeric ratio: > 15 : 1 (1H NMR). – 1H NMR
(200 MHz, CDCl3): δ = 1.08, 1.15, 1.16 and 1.25 (4s, each
9H, piv-CH3), 2.66 – 2.75 (m, 2H, CH2C=O), 3.68 (m, 1H,
H-5ꢀ), 3.85 (s, 3H, OCH3), 3.86 (m, 1H, H-6aꢀ), 3.90 (s, 3H,
OCH3, OCHꢀ ), 3.97 (d, 1H, J1 ,2 = 9.6 Hz, H-1), 4.08 (dd,
ꢀ
ꢀ
1H, J6b ,5 =36.4 Hz, J6b ,6a = 11.0 Hz, H-6bꢀ), 4.38 (dd,
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ
1H, Jvic = 3.6 Hz, Jvic = 11.0 Hz, aryl-CHN), 4.84 (dd,
1H, J3 ,4 = 3.2 Hz, J3 ,2 = 9.8 Hz, H-3ꢀ), 5.23 (d, 1H,
ꢀ
ꢀ
ꢀ
ꢀ
OCH3), 4.02 (m, 1H, H-6bꢀ), 4.28 (d, 1H, J1 ,2 = 9.5 Hz,
J4 ,3 = 3.0 Hz, H-4ꢀ), 5.48 (t, 1H, J = 9.7 Hz, H-2ꢀ), 6.76 –
6.84 (m, 3H, arom.). – 13C NMR (100.6 MHz, CDCl3):
δ = 24.95 (CH2), 27.09, 27.22 and 27.42 (piv-CH3), 31.05
and 32.87 (CH2), 38.71, 38.83 and 39.03 (piv-Cquart), 44.68
(CH2C=O), 45.76 (CH2C=Oꢀ), 49.27 (CH2Cl), 54.15 (alkyl-
CHN), 55.91 and 56.10 (OCH3, OCHꢀ3), 58.09 (aryl-CHN),
61.06 (C-6ꢀ), 65.27, 67.07, 71.56 and 72.53 (C-2ꢀ, C-3ꢀ,
C-4ꢀ, C-5ꢀ), 88.53 (C-1ꢀ), 111.22, 111.46, 120.98, 131.72,
149.32 and 149.53 (arom.), 176.52, 176.98 and 177.11
(pivC=O), 208.37 (C=O). – NMR data for 7: 13C NMR
(100.6 MHz, CDCl3): δ = 25.24, 31.53 and 31.88 (CH2),
44.45 (CH2C=O), 48.74 (CH2Cl), 54.15 and 55.91 (OCH3,
OCHꢀ3), 56.02 (aryl-CHN), 61.53 (C-6ꢀ), 65.82, 67.37 and
68.83 (C-2ꢀ, C-3ꢀ, C-4ꢀ, C-5ꢀ), 110.89 (C-1ꢀ), 110.89 and
120.12 (arom.), 130.90 (alkene), 133.88 (arom.), 146.86
(alkene), 197.95 (C=O).
ꢀ
ꢀ
ꢀ
ꢀ
H-1ꢀ), 4.72 (dd, 1H, Jvic = 5.7 Hz, Jvic = 11.1 Hz, aryl-CHN),
ꢀ
4.95 (dd, 1H, J3 ,4 = 3.1 Hz, J3 ,2 = 9.9 Hz, H-3ꢀ), 5.26
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ
ꢀ
(d, 1H, J = 8.1 Hz, =CHCO), 5.31 (d, 1H, J4 ,3 = 2.7 Hz,
H-4ꢀ), 5.66 (t, 1H, J = 9.8 Hz, H-2ꢀ), 6.79 – 6.91 (m, 3H,
arom.), 7.29 (d, 1H, J = 8.0 Hz, NCH=C). – 13C NMR
(100.6 MHz, CDCl3): δ = 27.07, 27.09 and 27.15 (piv-CH3),
38.65, 38.72, 28.81 und 39.04 (piv-Cquart), 43.94 (CH2C=O),
55.89 and 56.05 (OCH3), 60.90 (arylCHN), 60.94 (C-6ꢀ),
65.00, 66.75, 71.64 and 72.53 (C-2ꢀ, C-3ꢀ, C-4ꢀ, C-5ꢀ), 87.15
(C-1ꢀ), 103.79 (=CHCO), 110.64, 111.44, 120.45 and 130.15
(arom.), 149.29 (NCH=), 149.47 and 149.56 (arom.), 176.44,
176.79, 177.03 and 177.64 (pivC=O), 192.04 (C=O). –
C39H57NO12 (731.87): calcd. C 64.00, H 7.85, N 1.91; found
C 63.97, H 7.82, N 2.10.
(2S,6S)-N-(2,3,4,6-Tetra-O-pivaloyl-β-D-galactopyrano-
syl)-2-(3,4-dimethoxyphenyl)-6-(4-chlor-butyl)-piperidin-4-
one (6) and N-(2,3,4,6-tetra-O-pivaloyl-β-D-galacto-
pyranosyl)-1-amino-1-(3,4-dimethoxyphenyl)-9-chloro-4-
nonen-3-one (7)
(2S,6S)-N-(2,3,4,6-Tetra-O-pivaloyl-β-D-galactopyranos-
yl)-2-(3,4-dimethoxyphenyl)-6-(4-(1-ethoxyethyloxy)-butyl)-
piperidin-4-one (8)
Dibromomethane (5 – 10 drops) was added to a stirred
To stirred magnesium cuttings (0.39 g, 16 mmol) in
suspension of magnesium cuttings (0.12 g, 10 mmol) in tetrahydrofuran (12 mL) 4-chlorobutyl-(1-ethoxy)ethyl ether
diethyl ether (10 mL). After opacity occurred the mixture (2.17 g, 12 mmol) was given. After addition of a few drops
◦
was cooled to 0 C, and 1-bromo-4-chlorobutane (0.58 mL, of dibromomethane the mixture was heated under reflux
Unauthenticated
Download Date | 11/18/19 3:21 AM